Literature DB >> 19436827

Chronic fatigue syndrome and mitochondrial dysfunction.

Sarah Myhill, Norman E Booth, John McLaren-Howard.   

Abstract

This study aims to improve the health of patients suffering from chronic fatigue syndrome (CFS) by interventions based on the biochemistry of the illness, specifically the function of mitochondria in producing ATP (adenosine triphosphate), the energy currency for all body functions, and recycling ADP (adenosine diphosphate) to replenish the ATP supply as needed. Patients attending a private medical practice specializing in CFS were diagnosed using the Centers for Disease Control criteria. In consultation with each patient, an integer on the Bell Ability Scale was assigned, and a blood sample was taken for the "ATP profile" test, designed for CFS and other fatigue conditions. Each test produced 5 numerical factors which describe the availability of ATP in neutrophils, the fraction complexed with magnesium, the efficiency of oxidative phosphorylation, and the transfer efficiencies of ADP into the mitochondria and ATP into the cytosol where the energy is used. With the consent of each of 71 patients and 53 normal, healthy controls the 5 factors have been collated and compared with the Bell Ability Scale. The individual numerical factors show that patients have different combinations of biochemical lesions. When the factors are combined, a remarkable correlation is observed between the degree of mitochondrial dysfunction and the severity of illness (P<0.001). Only 1 of the 71 patients overlaps the normal region. The "ATP profile" test is a powerful diagnostic tool and can differentiate patients who have fatigue and other symptoms as a result of energy wastage by stress and psychological factors from those who have insufficient energy due to cellular respiration dysfunction. The individual factors indicate which remedial actions, in the form of dietary supplements, drugs and detoxification, are most likely to be of benefit, and what further tests should be carried out.

Entities:  

Year:  2009        PMID: 19436827      PMCID: PMC2680051     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  47 in total

Review 1.  Nutrient supply and mitochondrial function.

Authors:  T Y Aw; D P Jones
Journal:  Annu Rev Nutr       Date:  1989       Impact factor: 11.848

Review 2.  Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration.

Authors:  G D Zeevalk; L P Bernard; C Song; M Gluck; J Ehrhart
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

Review 3.  Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging.

Authors:  Bruce N Ames; Hani Atamna; David W Killilea
Journal:  Mol Aspects Med       Date:  2005 Aug-Oct

4.  Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome.

Authors:  R S Richards; T K Roberts; N R McGregor; R H Dunstan; H L Butt
Journal:  Redox Rep       Date:  2000       Impact factor: 4.412

5.  Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome.

Authors:  S Fulle; P Mecocci; G Fanó; I Vecchiet; A Vecchini; D Racciotti; A Cherubini; E Pizzigallo; L Vecchiet; U Senin; M F Beal
Journal:  Free Radic Biol Med       Date:  2000-12-15       Impact factor: 7.376

Review 6.  Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance.

Authors:  R Baker; E J Shaw
Journal:  BMJ       Date:  2007-09-01

7.  Serum levels of carnitine in chronic fatigue syndrome: clinical correlates.

Authors:  A V Plioplys; S Plioplys
Journal:  Neuropsychobiology       Date:  1995       Impact factor: 2.328

8.  Symptoms of autonomic dysfunction in chronic fatigue syndrome.

Authors:  J L Newton; O Okonkwo; K Sutcliffe; A Seth; J Shin; D E J Jones
Journal:  QJM       Date:  2007-07-07

9.  Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle.

Authors:  R J Lane; M C Barrett; D J Taylor; G J Kemp; R Lodi
Journal:  Neuromuscul Disord       Date:  1998-05       Impact factor: 4.296

10.  Experimental evidence for interpretive but not attention biases towards somatic information in patients with chronic fatigue syndrome.

Authors:  Rona Moss-Morris; Keith J Petrie
Journal:  Br J Health Psychol       Date:  2003-05
View more
  94 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

Review 2.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

3.  A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.

Authors:  Katrine Brække Norheim; Stephanie Le Hellard; Gunnel Nordmark; Erna Harboe; Lasse Gøransson; Johan G Brun; Marie Wahren-Herlenius; Roland Jonsson; Roald Omdal
Journal:  Rheumatol Int       Date:  2013-09-03       Impact factor: 2.631

4.  The Long Haul of COVID-19 Recovery: Immune Rejuvenation versus Immune Support.

Authors:  Jeffrey S Bland
Journal:  Integr Med (Encinitas)       Date:  2020-12

5.  Metabolic myopathies.

Authors:  Salvatore DiMauro; Caterina Garone; Ali Naini
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

6.  Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome.

Authors:  A R Light; L Bateman; D Jo; R W Hughen; T A Vanhaitsma; A T White; K C Light
Journal:  J Intern Med       Date:  2011-07-13       Impact factor: 8.989

7.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

Review 8.  Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.

Authors:  Michael Maes; Frank N M Twisk
Journal:  BMC Med       Date:  2010-06-15       Impact factor: 8.775

9.  Gut inflammation in chronic fatigue syndrome.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr Metab (Lond)       Date:  2010-10-12       Impact factor: 4.169

10.  Non-Hodgkin's Lymphoma Reversal with Dichloroacetate.

Authors:  Dana F Flavin
Journal:  J Oncol       Date:  2010-09-16       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.